# Clarapath

> Clarapath is a Hawthorne, New York medical robotics company that automates one of the most manual steps in cancer diagnosis: cutting and transferring paper-thin tissue sections onto slides for pathologists to read. Its flagship system, SectionStar, combines robotics, machine vision and AI to standardize tissue sectioning, cut turnaround times and ease chronic staffing shortages in histology labs. Founded in 2014 out of neuroanatomy research at Cold Spring Harbor Laboratory, the company has raised roughly $75 million and works with partners including the Mayo Clinic and Northwell Health.

- **Founded:** 2014
- **Headquarters:** Hawthorne, New York, United States
- **Founders:** Partha Mitra (Founder / Scientific originator (Cold Spring Harbor Laboratory neuroanatomy research))
- **Team size:** ~67 employees
- **Products:** SectionStar, Telehistology, TrimStar Pro, Crosscope Dx (digital pathology), Consulting Services
- **Notable:** Raised approximately $75M total to date across rounds, including a $36M Series B-1 in July 2024., Passed first round of certifications and expanded its global headquarters (2022)., Acquired digital-pathology AI firm Crosscope in 2023, adding software and machine learning to its robotics stack.

## Products & services

- **SectionStar** — Fully automated, all-in-one robotic tissue sectioning, transfer and quality-control system. Combines robotics, machine vision and AI to cut sections at user-defined 3-10 micron thickness, with roughly 72-block / 200-slide capacity per session and 24/7/365 operation. Uses a patented tape-transfer method that avoids traditional waterbath artifacts.
- **Telehistology** — Remote operation capability allowing a technician to run SectionStar tissue sectioning from anywhere, addressing geographic and staffing constraints.
- **TrimStar Pro** — Companion product in Clarapath's histology automation line (tissue trimming/preparation).
- **Crosscope Dx (digital pathology)** — AI-powered telepathology and slide-management platform acquired in 2023; provides workflow tools and machine-learning decision support for pathologists, connecting Clarapath's hardware to digital diagnosis.
- **Consulting Services** — Professional consultation for pathology labs on workflow modernization and automation adoption.

## Achievements

- Raised approximately $75M total to date across rounds, including a $36M Series B-1 in July 2024.
- Passed first round of certifications and expanded its global headquarters (2022).
- Acquired digital-pathology AI firm Crosscope in 2023, adding software and machine learning to its robotics stack.
- Secured strategic collaboration and investment from Mayo Clinic (2024).
- Developed a patented tape-transfer sectioning method that eliminates traditional waterbath artifacts.

## Latest updates

- **2024-07** — Closed $36M Series B-1 round led by Northwell Ventures to accelerate SectionStar commercialization, sales/service expansion and R&D.
- **2024-04** — Announced strategic collaboration with Mayo Clinic to advance pathology tissue processing.
- **2023-03** — Acquired Crosscope, an AI digital-pathology software company, retaining its Mountain View and Mumbai teams.
- **2022-06** — Passed first round of certifications and expanded global headquarters in Hawthorne, NY.
- **2021-11** — Raised $32M in additional funding to advance its medical robotics platform.

## Links

- Website: https://clarapath.com
- LinkedIn: https://www.linkedin.com/company/clarapath-inc
- Twitter/X: https://twitter.com/clarapath_inc

---

Profile page: https://yespress.io/clarapath
Published by YesPress — https://yespress.io
Last updated: 2026-07-22